Current guidelines recommend that a diagnosis of AADC deficiency should be based on the identification of compound heterozygous or homozygous pathogenic variants in the DDC gene combined with either CSF analysis or measurement of plasma AADC activity. The gene discussed is DDC; the disease is hyperinsulinemic hypoglycemia, familial, 4.